BioLife Fund

CIT GAP BioLife Fund makes seed-stage equity investments in Virginia-based life science companies with a high potential for achieving rapid growth and generating significant economic return.

Industries Served

  • Biotechnology
  • Biopharmaceuticals
  • Medical Devices
  • Laboratory Instrumentation
  • Diagnostics
  • Healthcare IT
  • Nutraceuticals
  • Agricultural Biotechnology
  • Biomaterials

Geographic Focus

CIT GAP Funds invests exclusively in companies headquartered, and with an express desire to grow in, the Commonwealth of Virginia.

Key Resources

CIT GAP Funds Investment Criteria.

Application

For consideration by CIT GAP Funds, please email your executive summary to gap@cit.org.  Preferred executive summary format can be found here.